FDA Inspection 1323714 — Savara Inc.
The FDA completed an inspection of Savara Inc. on Apr 3, 2026 in Yardley, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 3, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Yardley, PA (United States)
Additional Details
Sponsor, Contract Research Organization